|
(Health-NewsWire.Net, May 28, 2021 ) According to the new market research report Stable Isotope Labeling Market is projected to grow at a CAGR of 3.0% during the forecast period to reach USD 312 million by 2024 from USD 269 million in 2019.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=53034199
The growth of the Stable Isotope Labeling Market is driven majorly by the rising proteomics research, increase in research activities in the pharmaceutical and biotechnology sector, and the rising prevalence of cancer.
In 2019, North America dominated the stable isotope labeled compounds market, followed by Europe. The major factors driving the growth of this market include the growth of the pharmaceutical and biopharmaceutical industry, the growth of the Canadian pharmaceutical industry, the large nuclear industry in the US and the availability of funding in North American countries.
Based on application, the stable isotope labeled compounds market is segmented into research, clinical diagnostics, industrial applications, and other applications. The research segment accounted for the largest share of the stable isotope-labeled compounds market in 2019, owing to rising research activities in the biomedical, pharmaceutical, environmental & ecological, and agricultural sectors.
Based on type, the stable isotope labeled compounds industry is segmented into C-13, N-15, O-18, H-2 (deuterium), and other isotopes. The H-2 labeled compounds segment accounted for the largest share of the stable isotope-labeled compounds market in 2019. The large share of this segment can be attributed to the increasing pharmaceutical research conducted using deuterium and the growing nuclear industry. This growth in this segment is driven primarily by increasing drug research in the pharmaceutical industry and the rising availability of deuterium-labeled compounds.
Request Free Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=53034199
The prominent players in the Stable Isotope Labeling Market include PerkinElmer Inc. (US), Merck KGaA (Germany), Cambridge Isotope Laboratories, Inc. (US), Medical Isotopes, Inc. (US), Omicron Biochemicals, Inc. (US), Trace Sciences International (US), URENCO Limited (UK), IsoSciences, LLC (US), Alsachim (France), Taiyo Nippon Sanso Corporation (Japan), and Rotem Industries Israel Ltd. (Israel).
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
sales@marketsandmarkets.com
MarketsandMarkets™
Mr. Aashish Mehra
1-888-600-6441
raviraj.tak@marketsandmarkets.com
Source: EmailWire.Com 
|
